China
Chinese biotech companies target Europe for growth
Chinese biotechnology companies are increasingly targeting Europe as they seek licensing deals, investment and commercial growth beyond a crowded domestic market. Their expansion presents both partnership opportunities and fresh competition for Swiss pharmaceutical groups such as Roche and Novartis.

Article content structure is incomplete. Please refresh or contact support.